​Antibiotic shows promise against Lyme disease at a fraction of the dosage

A Northwestern University study reveals that piperacillin, a common antibiotic, effectively treats Lyme disease in mice at a much lower dose than doxycycline, the current standard. This reduced dosage minimizes harm to beneficial gut bacteria, a significant drawback of existing treatments. Piperacillin, already FDA-approved, could also potentially serve as a preventive measure against Lyme disease following tick bites.

Most Recent